Haleos Labs Limited (NSE:SMSLIFE)
India flag India · Delayed Price · Currency is INR
1,122.40
-18.20 (-1.60%)
Oct 24, 2025, 3:29 PM IST

Haleos Labs Company Description

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.

The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products.

It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025.

Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

Haleos Labs Limited
CountryIndia
Founded1990
IndustryBiotechnology
SectorHealthcare
Employees592
CEOTalluri Veera Venkata Murthy

Contact Details

Address:
Plot No. 19-III
Hyderabad, 500096
India
Phone91 40 6628 8888
Websitesmslife.in

Stock Details

Ticker SymbolSMSLIFE
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE320X01016
SIC Code2834

Key Executives

NamePosition
Talluri Veera Venkata Satyanarayana MurthyMD and Executive Director
Nadella Rajendra PrasadChief Financial Officer and GM of Accounts & Finance
Trupti Ranjan MohantyCompany Secretary and Compliance Officer
Talluri Venkata PraveenChief Marketing Officer and Executive Director
Sudeepthi GopineediWhole-Time Director
Lakshminarayana SomisettyGeneral Manager of Operations
Vijay Babu ChirumamillaManager of Admin/HR/IT